Anti-worm Medication Market 2031: Share and Forecast
The Anti-worm Medication Market is expected to register a CAGR of 4.8% from 2023 to 2031, with a market size expanding from US$ XX million in 2023 to US$ XX Million by 2031.
The report is segmented by Type (Albenza, Vermox). Futher, it is segmented based on Application (Human, Veterinary). The global analysis is further broken-down at regional level and major countries. The report offers the value in USD for the above analysis and segments.
Purpose of the ReportThe report Anti-worm Medication Market by The Insight Partners aims to describe the present landscape and future growth, top driving factors, challenges, and opportunities. This will provide insights to various business stakeholders, such as:
- Technology Providers/Manufacturers: To understand the evolving market dynamics and know the potential growth opportunities, enabling them to make informed strategic decisions.
- Investors: To conduct a comprehensive trend analysis regarding the market growth rate, market financial projections, and opportunities that exist across the value chain.
- Regulatory bodies: To regulate policies and police activities in the market with the aim of minimizing abuse, preserving investor trust and confidence, and upholding the integrity and stability of the market.
Anti-worm Medication Market Segmentation
Type- Albenza
- Vermox
- Human
- Veterinary
Strategic Insights
Anti-worm Medication Market Growth Drivers- Increasing Prevalence of Worm Infections: Prevalence of worm infections is increasing across the world. Poor sanitation and hygiene practices in some regions heighten the infection rate, and effective treatment is necessary to kill the infection.
- Heightening Health Hazards: Increasing awareness about health hazards through parasitic infections has grown in the people. Information campaigns and health services advocate the necessity of deworming and thus influence the market for antiworm medications.
- Growing Animal Use: The use of anti-worms is also increasing in animal medicine. With an increase in the number of people having pets, there is a growing need for effective deworming products in animals.
- Shift to Natural Remedies: There is a noticeable trend toward natural and herbal anti-worm medication. Consumers are moving away from chemical medication, leading to a greater demand for a natural product.
- Telemedicine and Online Pharmacies: The boost in telemedicine and online pharmacies is helping revolutionize the access of anti-worm medication. Patients have an easy access now to prescriptions and medications, broadening their market reach.
- Focus on Preventive Healthcare: Preventive health activities in the form of deworming programs are gaining momentum. This activity is most pronounced in endemic areas, as a preventive approach would control the infection rate very quickly.
- Advances in Pharmaceutical Science: Advances in formulation and delivery mechanisms for drugs will enhance the therapeutic intensity of anti-worm drugs. New entities and combination regimens are being explored, leading to expanded treatment options and better patient outcomes.
- Regulatory Backing for Antiparasitic Medications: Regulatory agencies are now highly supportive of new antiparasitic drug development and subsequent approval. Regulatory support could speed up the availability of innovative treatments on the market.
- Expansion of Veterinary Products: The veterinary segment has huge growth opportunities. The demand for specific anti-worm drugs for pets and livestock can bring a good amount of money.
Market Report Scope
Key Selling Points
- Comprehensive Coverage: The report comprehensively covers the analysis of products, services, types, and end users of the Anti-worm Medication Market, providing a holistic landscape.
- Expert Analysis: The report is compiled based on the in-depth understanding of industry experts and analysts.
- Up-to-date Information: The report assures business relevance due to its coverage of recent information and data trends.
- Customization Options: This report can be customized to cater to specific client requirements and suit the business strategies aptly.
The research report on the Anti-worm Medication Market can, therefore, help spearhead the trail of decoding and understanding the industry scenario and growth prospects. Although there can be a few valid concerns, the overall benefits of this report tend to outweigh the disadvantages.
REGIONAL FRAMEWORK
Have a question?
Mrinal
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
The major factors driving the anti-worm medication market are:
1. Increasing Prevalence of Worm Infections.
2. Growing Animal Use.
The anti-worm medication market is expected to grow at a CAGR of 4.8%.
North America region accounts for highest revenue share in anti-worm medication market.
The final report will duly include market size and projection estimates for all the segments from 2021 to 2031, along with a revenue share and compound annual growth rate (%) for the regional/country-wise market wherein 2021-2022 are the historic years, 2023 is considered to be the base year, and the forecast will be provided till 2031, along with CAGR (%).
Bayer and Boehringer Ingelheim are the major companies operating in the anti-worm medication market.
Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2023 - 2031).
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Anti-worm Medication Market - By Type
1.3.2 Anti-worm Medication Market - By Application
1.3.3 Anti-worm Medication Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. ANTI-WORM MEDICATION MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. ANTI-WORM MEDICATION MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. ANTI-WORM MEDICATION MARKET - GLOBAL MARKET ANALYSIS
6.1. ANTI-WORM MEDICATION - GLOBAL MARKET OVERVIEW
6.2. ANTI-WORM MEDICATION - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING
7. ANTI-WORM MEDICATION MARKET - REVENUE AND FORECASTS TO 2028 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. ALBENZA
7.3.1. Overview
7.3.2. Albenza Market Forecast and Analysis
7.4. VERMOX
7.4.1. Overview
7.4.2. Vermox Market Forecast and Analysis
8. ANTI-WORM MEDICATION MARKET - REVENUE AND FORECASTS TO 2028 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. HUMAN
8.3.1. Overview
8.3.2. Human Market Forecast and Analysis
8.4. VETERINARY
8.4.1. Overview
8.4.2. Veterinary Market Forecast and Analysis
9. ANTI-WORM MEDICATION MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Anti-worm Medication Market Overview
9.1.2 North America Anti-worm Medication Market Forecasts and Analysis
9.1.3 North America Anti-worm Medication Market Forecasts and Analysis - By Type
9.1.4 North America Anti-worm Medication Market Forecasts and Analysis - By Application
9.1.5 North America Anti-worm Medication Market Forecasts and Analysis - By Countries
9.1.5.1 Canada Anti-worm Medication Market
9.1.5.1.1 Canada Anti-worm Medication Market by Type
9.1.5.1.2 Canada Anti-worm Medication Market by Application
9.1.5.2 Mexico Anti-worm Medication Market
9.1.5.2.1 Mexico Anti-worm Medication Market by Type
9.1.5.2.2 Mexico Anti-worm Medication Market by Application
9.1.5.3 US Anti-worm Medication Market
9.1.5.3.1 US Anti-worm Medication Market by Type
9.1.5.3.2 US Anti-worm Medication Market by Application
9.2. EUROPE
9.2.1 Europe Anti-worm Medication Market Overview
9.2.2 Europe Anti-worm Medication Market Forecasts and Analysis
9.2.3 Europe Anti-worm Medication Market Forecasts and Analysis - By Type
9.2.4 Europe Anti-worm Medication Market Forecasts and Analysis - By Application
9.2.5 Europe Anti-worm Medication Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Anti-worm Medication Market
9.2.5.1.1 Germany Anti-worm Medication Market by Type
9.2.5.1.2 Germany Anti-worm Medication Market by Application
9.2.5.2 France Anti-worm Medication Market
9.2.5.2.1 France Anti-worm Medication Market by Type
9.2.5.2.2 France Anti-worm Medication Market by Application
9.2.5.3 Italy Anti-worm Medication Market
9.2.5.3.1 Italy Anti-worm Medication Market by Type
9.2.5.3.2 Italy Anti-worm Medication Market by Application
9.2.5.4 Spain Anti-worm Medication Market
9.2.5.4.1 Spain Anti-worm Medication Market by Type
9.2.5.4.2 Spain Anti-worm Medication Market by Application
9.2.5.5 United Kingdom Anti-worm Medication Market
9.2.5.5.1 United Kingdom Anti-worm Medication Market by Type
9.2.5.5.2 United Kingdom Anti-worm Medication Market by Application
9.2.5.6 Rest of Europe Anti-worm Medication Market
9.2.5.6.1 Rest of Europe Anti-worm Medication Market by Type
9.2.5.6.2 Rest of Europe Anti-worm Medication Market by Application
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Anti-worm Medication Market Overview
9.3.2 Asia-Pacific Anti-worm Medication Market Forecasts and Analysis
9.3.3 Asia-Pacific Anti-worm Medication Market Forecasts and Analysis - By Type
9.3.4 Asia-Pacific Anti-worm Medication Market Forecasts and Analysis - By Application
9.3.5 Asia-Pacific Anti-worm Medication Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Anti-worm Medication Market
9.3.5.1.1 Australia Anti-worm Medication Market by Type
9.3.5.1.2 Australia Anti-worm Medication Market by Application
9.3.5.2 China Anti-worm Medication Market
9.3.5.2.1 China Anti-worm Medication Market by Type
9.3.5.2.2 China Anti-worm Medication Market by Application
9.3.5.3 India Anti-worm Medication Market
9.3.5.3.1 India Anti-worm Medication Market by Type
9.3.5.3.2 India Anti-worm Medication Market by Application
9.3.5.4 Japan Anti-worm Medication Market
9.3.5.4.1 Japan Anti-worm Medication Market by Type
9.3.5.4.2 Japan Anti-worm Medication Market by Application
9.3.5.5 South Korea Anti-worm Medication Market
9.3.5.5.1 South Korea Anti-worm Medication Market by Type
9.3.5.5.2 South Korea Anti-worm Medication Market by Application
9.3.5.6 Rest of Asia-Pacific Anti-worm Medication Market
9.3.5.6.1 Rest of Asia-Pacific Anti-worm Medication Market by Type
9.3.5.6.2 Rest of Asia-Pacific Anti-worm Medication Market by Application
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Anti-worm Medication Market Overview
9.4.2 Middle East and Africa Anti-worm Medication Market Forecasts and Analysis
9.4.3 Middle East and Africa Anti-worm Medication Market Forecasts and Analysis - By Type
9.4.4 Middle East and Africa Anti-worm Medication Market Forecasts and Analysis - By Application
9.4.5 Middle East and Africa Anti-worm Medication Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Anti-worm Medication Market
9.4.5.1.1 South Africa Anti-worm Medication Market by Type
9.4.5.1.2 South Africa Anti-worm Medication Market by Application
9.4.5.2 Saudi Arabia Anti-worm Medication Market
9.4.5.2.1 Saudi Arabia Anti-worm Medication Market by Type
9.4.5.2.2 Saudi Arabia Anti-worm Medication Market by Application
9.4.5.3 U.A.E Anti-worm Medication Market
9.4.5.3.1 U.A.E Anti-worm Medication Market by Type
9.4.5.3.2 U.A.E Anti-worm Medication Market by Application
9.4.5.4 Rest of Middle East and Africa Anti-worm Medication Market
9.4.5.4.1 Rest of Middle East and Africa Anti-worm Medication Market by Type
9.4.5.4.2 Rest of Middle East and Africa Anti-worm Medication Market by Application
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Anti-worm Medication Market Overview
9.5.2 South and Central America Anti-worm Medication Market Forecasts and Analysis
9.5.3 South and Central America Anti-worm Medication Market Forecasts and Analysis - By Type
9.5.4 South and Central America Anti-worm Medication Market Forecasts and Analysis - By Application
9.5.5 South and Central America Anti-worm Medication Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Anti-worm Medication Market
9.5.5.1.1 Brazil Anti-worm Medication Market by Type
9.5.5.1.2 Brazil Anti-worm Medication Market by Application
9.5.5.2 Argentina Anti-worm Medication Market
9.5.5.2.1 Argentina Anti-worm Medication Market by Type
9.5.5.2.2 Argentina Anti-worm Medication Market by Application
9.5.5.3 Rest of South and Central America Anti-worm Medication Market
9.5.5.3.1 Rest of South and Central America Anti-worm Medication Market by Type
9.5.5.3.2 Rest of South and Central America Anti-worm Medication Market by Application
10. INDUSTRY LANDSCAPE
10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
11. ANTI-WORM MEDICATION MARKET, KEY COMPANY PROFILES
11.1. BAYER
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. LASA SUPERGENERICS LIMITED
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. SALIUS PHARMA
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. BOEHRINGER INGELHEIM
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. ZOETIS
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. DECHRA
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. MERCK ANIMAL HEALTH
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. ELANCO
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. SUPHARMA CHEM
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Products and Services
11.9.4. Financial Overview
11.9.5. SWOT Analysis
11.9.6. Key Developments
11.10. VIRBAC
11.10.1. Key Facts
11.10.2. Business Description
11.10.3. Products and Services
11.10.4. Financial Overview
11.10.5. SWOT Analysis
11.10.6. Key Developments
12. APPENDIX
12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
1. Bayer
2. Lasa Supergenerics Limited
3. Salius Pharma
4. Boehringer Ingelheim
5. Zoetis
6. Dechra
7. Merck Animal Health
8. Elanco
9. Supharma Chem
10. Virbac
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For